Silence Therapeutics (SLN)
NASDAQ:SLN
Silence Therapeutics (SLN) Ownership Overview
22.15%
Insiders
0.10% Mutual Funds
32.28% Other Institutional Investors
0.46% ETFs
45.02% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (SLN) stock is a mix of institutional, retail, and individual investors. Approximately 32.83% of the company’s stock is owned by Institutional Investors, 22.15% is owned by Insiders, and 45.02% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,461,299 | Insider | 22.15% | 69,358,412 | |
| 203,391 | Institution | 0.43% | 1,348,482 | |
| 62,459 | Institution | 0.13% | 414,103 | |
| 29,538 | Institution | 0.06% | 195,837 | |
| 11,600 | Institution | 0.02% | 76,908 | |
| 9,434 | Institution | 0.02% | 62,547 | |
| 7,708 | Institution | 0.02% | 51,104 | |
| 4,238 | Institution | <0.01% | 28,098 | |
| 2,621 | Institution | <0.01% | 17,377 | |
| 2,079 | Institution | <0.01% | 13,784 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 29,538 | Institution | 0.06% | 195,837 | |
| 11,600 | Institution | 0.02% | 76,908 | |
| 4,238 | Institution | <0.01% | 28,098 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 140,285 | Institution | 0.30% | 930,090 | |
| 31,918 | Institution | 0.07% | 220,553 | |
| 9,434 | Institution | 0.02% | 65,189 | |
| 2,621 | Institution | <0.01% | 17,377 |
FAQ
Who Owns Silence Therapeutics (SLN)?
According to the latest TipRanks data, approximately 32.28% of the company's stock is held by institutional investors, 22.15% is held by insiders, and 45.02% is held by retail investors.
What percentage of Silence Therapeutics (SLN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.28% of Silence Therapeutics (SLN) stock is held by institutional investors.
What percentage of Silence Therapeutics (SLN) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.02% of Silence Therapeutics (SLN) stock is held by retail investors.
Who owns the most shares of Silence Therapeutics (SLN)?
Richard Ian Griffiths owns the most shares of Silence Therapeutics (SLN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.